Expert and Patient Perspectives on Comprehensive Multiple Myeloma Treatment


Dr Kumar, Dr Patel, Falbo, and Ahlstrom highlight the importance of community-based discussions regarding adverse effects in multiple myeloma, the benefits of considering the whole treatment course, and subgroup analyses from the MAIA trial.

Welcome to OncLive On Air®! I’m your host today, Ashling Wahner.

OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, we passed the mic to Shaji Kumar, MD, a consultant in the Division of Hematology in the Department of Internal Medicine and a professor of medicine at Mayo Clinic in Rochester, Minnesota. Dr Kumar moderated an OncLive® Insights discussion on advances in the treatment of multiple myeloma. Rounding out the discussion with expert and patient perspectives were Krina K. Patel, MD, MSc, an associate professor in the Department of Lymphoma/Myeloma in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, Bonnie Falbo, a caregiver and patient advocate, and Jenny Ahlstrom, a patient with multiple myeloma.

In this exclusive conversation, Kumar, Patel, Falbo, and Ahlstrom highlighted the importance of comprehensive, community-based discussions regarding adverse effects in multiple myeloma, discussed the benefits of considering each aspect of treatment within the context of the whole treatment course, and interpreted subgroup analyses from the phase 3 MAIA trial (NCT02252172).


That’s all we have for today! Thank you for listening to this episode of OncLive On Air®. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit and sign up for our e-newsletters.

OncLive® is also on social media. On Twitter, follow us at @OncLive and @OncLiveSOSS. On Facebook, like us at OncLive and OncLive State of the Science Summit and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air®, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air®.

*OncLive On Air® is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.

Related Videos
Ariel Grajales-Cruz, MD
Jeremy L. Ramdial, MD, assistant professor, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Rahul Banerjee, MD, FACP, assistant professor, Clinical Research Division, Fred Hutchinson Cancer Center; assistant professor, Division of Hematology and Oncology, University of Washington
Neil D. Gross, MD, FACS
Muhamad Alhaj Moustafa, MD, MS, hematologist, medical oncologist, Departments of Hematology and Oncology (Medical), Mayo Clinic
Salman R. Punekar, MD, Mayo Clinic
Michael J. Overman, MD, The University of Texas MD Anderson Cancer Center,
Jeffrey Zonder, MD
A panel of 6 experts on follicular lymphoma and mantle cell lymphoma seated at a long desk
Eleonora Dondossola, PhD